# reload+after+2024-01-21 21:27:40.553378
address1§350 Hills Street
address2§Suite 106
city§Richland
state§WA
zip§99354
country§United States
phone§509 375 1202
fax§509 267 3670
website§https://www.perspectivetherapeutics.com
industry§Medical Devices
sector§Healthcare
longBusinessSummary§Perspective Therapeutics, Inc., together with its subsidiaries, develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. The company was formerly known as Isoray, Inc. and changed its name to Perspective Therapeutics, Inc. in February 2022. Perspective Therapeutics, Inc. was founded in 1998 and is based in Richland, Washington.
fullTimeEmployees§91
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Johan M. Spoor', 'age': 51, 'title': 'CEO & Director', 'yearBorn': 1972, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Jonathan R. Hunt', 'age': 56, 'title': 'CFO & Co-Principal Financial Officer', 'yearBorn': 1967, 'fiscalYear': 2009, 'totalPay': 144119, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Shane  Cobb', 'title': 'Executive Vice President of Operations', 'fiscalYear': 2009, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Mark J. Austin CPA', 'age': 36, 'title': 'VP of Finance, Controller, Co-Principal Financial, Principal Accounting Officer & Secretary', 'yearBorn': 1987, 'fiscalYear': 2009, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Michael K. Schultz Ph.D.', 'title': 'Chief Science Officer', 'fiscalYear': 2009, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Andrew  Bright', 'title': 'Executive Vice President of Brachytherapy', 'fiscalYear': 2009, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Markus  Puhlmann M.B.A., M.D.', 'age': 57, 'title': 'Chief Medical Officer', 'yearBorn': 1966, 'fiscalYear': 2009, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Amos  Hedt BA, PGradDip', 'title': 'Chief Business Strategy Officer', 'fiscalYear': 2009, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Frances L. Johnson M.D.', 'title': 'Chief Innovation Officer', 'fiscalYear': 2009, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. David  Hauser Ph.D.', 'title': 'Senior Vice President of Clinical Operations', 'fiscalYear': 2009, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1262217600
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§1.623
priceToSalesTrailing12Months§27.576733
currency§USD
dateShortInterest§1702598400
forwardEps§-0.12
exchange§ASE
quoteType§EQUITY
shortName§Perspective Therapeutics, Inc.
longName§Perspective Therapeutics, Inc.
firstTradeDateEpochUtc§1131633000
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§a1707dc4-5cfd-3847-8a2b-6645f98c24d4
gmtOffSetMilliseconds§-18000000
targetHighPrice§1.5
targetLowPrice§1.2
targetMeanPrice§1.35
targetMedianPrice§1.35
recommendationMean§1.5
recommendationKey§strong_buy
numberOfAnalystOpinions§2
quickRatio§2.429
grossMargins§0.051680002
ebitdaMargins§0.0
trailingPegRatio§None
